Hematopoietic Stem Cell Dysfunction in the Elderly After Severe Injury
| Status: | Recruiting |
|---|---|
| Conditions: | Hospital |
| Therapuetic Areas: | Other |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 9/22/2018 |
| Start Date: | January 2014 |
| End Date: | October 2019 |
| Contact: | Jennifer D Lanz, MSN |
| Email: | jennifer.lanz@surgery.ufl.edu |
| Phone: | 352-273-5497 |
Hematopoietic Stem Cell Dysfunction in the Elderly After Severe Injury: Chronic Stress and Anemia Recovery Following Major Trauma
Traumatic injury is a leading cause of morbidity and mortality in young adults, and remains a
substantial economic and health care burden. Despite decades of promising preclinical and
clinical investigations in trauma, investigators understanding of these entities is still
incomplete, and few therapies have shown success. During severe trauma, bone marrow
granulocyte stores are rapidly released into the peripheral circulation. This release
subsequently induces the expansion and repopulation of empty or evacuated space by
hematopoietic stem cells (HSCs). Although the patient experiences an early loss of bone
marrow myeloid-derived cells, stem cell expansion is largely skewed towards the repopulation
of the myeloid lineage/compartment. The hypothesis is that this 'emergency myelopoiesis' is
critical for the survival of the severely traumatized and further, failure of the emergency
myelopoietic response is associated with global immunosuppression and susceptibility to
secondary infection. Also, identifying the release of myeloid derived suppressor cells
(MDSCs) in the circulation of human severe trauma subjects. This process is driven by HSCs in
the bone marrow of trauma subjects. Additionally, MDSCs may have a profound effect on the
nutritional status of the host. The appearance of these MDSCs after trauma is associated with
a loss of muscle tissue in these subjects. This muscle loss and possible increased catabolism
have huge effects on long term outcomes for these subjects. It is the investigator's goal to
understand the differences that occur in these in HSCs and muscle cells as opposed to
non-injured and non-infected controls. This work will lead to a better understanding of the
myelopoietic and catabolic response following trauma.
substantial economic and health care burden. Despite decades of promising preclinical and
clinical investigations in trauma, investigators understanding of these entities is still
incomplete, and few therapies have shown success. During severe trauma, bone marrow
granulocyte stores are rapidly released into the peripheral circulation. This release
subsequently induces the expansion and repopulation of empty or evacuated space by
hematopoietic stem cells (HSCs). Although the patient experiences an early loss of bone
marrow myeloid-derived cells, stem cell expansion is largely skewed towards the repopulation
of the myeloid lineage/compartment. The hypothesis is that this 'emergency myelopoiesis' is
critical for the survival of the severely traumatized and further, failure of the emergency
myelopoietic response is associated with global immunosuppression and susceptibility to
secondary infection. Also, identifying the release of myeloid derived suppressor cells
(MDSCs) in the circulation of human severe trauma subjects. This process is driven by HSCs in
the bone marrow of trauma subjects. Additionally, MDSCs may have a profound effect on the
nutritional status of the host. The appearance of these MDSCs after trauma is associated with
a loss of muscle tissue in these subjects. This muscle loss and possible increased catabolism
have huge effects on long term outcomes for these subjects. It is the investigator's goal to
understand the differences that occur in these in HSCs and muscle cells as opposed to
non-injured and non-infected controls. This work will lead to a better understanding of the
myelopoietic and catabolic response following trauma.
This is a prospective study to understand how trauma injuries changes the hematopoeitic stem
cells (HSCs) in the bone marrow and muscle cells after trauma injury in elderly subjects is
different when compared to non-injured subjects.
There will be three groups for this study: 1) Elective hip surgery subjects, 2) Trauma
subjects and 3) deidentified bone marrow of healthy controls.
Samples of bone marrow and a blood sample will be collected at the time of surgery. The
deidentified bone marrow of healthy controls will come from a tissue bank.
The blood will be used to perform PB colony assays, ELISAs to test for the following
parameters: EPO, G-CSF, Reticulocyte, iron levels and cytokines and inflammatory markers.
The bone marrow and blood samples will be processed and sorted to isolate hematopoeitic stem
cells for genomic content to determine genomic expression, oxidative stress, mitochondrial
activity, apoptosis, autophagy, analysis of circulating erythroid progenitor cells,
reticulocytes, granulocyte-colony stimulating factor assays, erythropoietin and iron levels.
Clinical data and hemodynamic measurements will be collected daily while subjects are
hospitalized and trauma surgery subjects will be followed to evaluate for malunion and
subsequent additional surgical procedures for repair.
cells (HSCs) in the bone marrow and muscle cells after trauma injury in elderly subjects is
different when compared to non-injured subjects.
There will be three groups for this study: 1) Elective hip surgery subjects, 2) Trauma
subjects and 3) deidentified bone marrow of healthy controls.
Samples of bone marrow and a blood sample will be collected at the time of surgery. The
deidentified bone marrow of healthy controls will come from a tissue bank.
The blood will be used to perform PB colony assays, ELISAs to test for the following
parameters: EPO, G-CSF, Reticulocyte, iron levels and cytokines and inflammatory markers.
The bone marrow and blood samples will be processed and sorted to isolate hematopoeitic stem
cells for genomic content to determine genomic expression, oxidative stress, mitochondrial
activity, apoptosis, autophagy, analysis of circulating erythroid progenitor cells,
reticulocytes, granulocyte-colony stimulating factor assays, erythropoietin and iron levels.
Clinical data and hemodynamic measurements will be collected daily while subjects are
hospitalized and trauma surgery subjects will be followed to evaluate for malunion and
subsequent additional surgical procedures for repair.
Severe Trauma Population
Inclusion criteria will be:
1. All adults (age ≥18)
2. Blunt and/or penetrating trauma resulting in long bone or pelvic fractures requiring
ORIF or closed reduction percutaneous pinning (CRPP).
3. Blunt and/or penetrating trauma patient with either:
a. hemorrhagic shock defined by: i. systolic BP (SBP) ≤ 90 mmHg or ii. mean arterial
pressure≤ 65 mmHg or iii. base deficit (BD) ≥ 5 meq or iv. lactate ≥ 2 b. Or injury
severity score (ISS) greater than or equal to 15.
4. Ability to obtain Informed Consent prior to repair of injury.
Exclusion Criteria will be:
1. Patients not expected to survive greater than 48 hours.
2. Prisoners.
3. Pregnancy.
4. Patients receiving chronic corticosteroids or immunosuppression therapies.
5. Previous bone marrow transplantation.
6. Patients with End Stage Renal Disease.
7. Patients with any pre-existing hematological disease.
Elective Hip Repair Population
Inclusion criteria will be:
1. All adults (age ≥18)
2. Patient undergoing elective hip repair for non-infectious reasons.
3. Ability to obtain Informed Consent prior to operation.
Exclusion Criteria will be:
1. Pregnancy.
2. Prisoners.
3. Patients receiving chronic corticosteroids or immunosuppression therapies.
4. Previous Chemotherapy or Radiation.
5. Pre-existing conditions such as pathological fractures, cancer, history of HIV, or
history of connective tissue disease.
6. Previous bone marrow transplantation.
7. Patients with End Stage Renal Disease.
8. Patients with any pre-existing hematological disease.
We found this trial at
1
site
Gainesville, Florida 32610
Phone: 352-273-5497
Click here to add this to my saved trials
